Amvuttra 25 mg solution for injection in pre-filled syringe
*Company:
Alnylam UK Ltd.Status:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 10 February 2025
File name
AMVUTTRA_IE-PIL- Clean.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 2 - what you need to know - contraindications
- Change to section 3 - how to take/use
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 5 - how to store or dispose
- Change to section 6 - date of revision
- Change to section 7 - Instructions for use
Updated on 10 February 2025
File name
AMVUTTRA _IE -SmPC- Clean.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 December 2024
File name
AMVUTTRA _IE-SmPC-EN-CLN.pdf
Reasons for updating
- Change to section 5.3 - Preclinical safety data
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 21 February 2023
File name
Amvuttra PIL.pdf
Reasons for updating
- New PIL for new product
Updated on 21 February 2023
File name
Amvuttra SmPC.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Alnylam UK Ltd.
Address:
Braywick Gate, Braywick Road, Maidenhead SL6 1DA, United KingdomMedical Information E-mail:
medinfo@alnylam.comMedical Information Facsimile:
+44 (0) 1255 444 400Medical Information Direct Line:
+44 1628878592